Synopsis of unbalanced chromosomal aberrations in neuroblastoma by comparative genomic hybridization

被引:2
作者
Brinkschmidt, C
Christiansen, H
Terpe, HJ
Simon, R
Lampert, F
Bocker, W
Storkel, S
机构
[1] UNIV MUNSTER, GERHARD DOMAGK INST PATHOL, D-4400 MUNSTER, GERMANY
[2] UNIV GIESSEN, KINDERKLIN, GIESSEN, GERMANY
[3] UNIV WITTEN HERDECKE, INST PATHOL, WITTEN, GERMANY
来源
PATHOLOGE | 1996年 / 17卷 / 05期
关键词
neuroblastoma; comparative genomic hybridization;
D O I
10.1007/s002920050174
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Neuroblastoma is the most frequent extracranial solid tumor of early childhood. Histologically and genetically, neuroblastoma represents a heterogeneous group of tumors with significant differences in clinical behavior. In the past, several different characteristic chromosomal aberrations of neuroblastoma have been described, of which a deletion on chromosome Ip and N-myc amplification have been shown to be of major prognostic significance, However, the role of various other nonrandom DNA imbalances in tumor development and progression needs to be clarified, Taking advantage of the recently established comparative genomic hybridization (CGH), we show that this method is able to accurately detect chromosomal imbalances of known prognostic impact. As CGH gives a comprehensive picture of genetic imbalances in just one experiment, it additionally sheds light on other abnormalities of possible prognostic relevance. We therefore recommend further use of this method not only in the field of resarch but also for the purpose of genetic routine diagnostics in neuroblastoma.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 23 条
[1]  
Ambros PF, 1995, ONKOLOGIE, V18, P548
[2]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[3]   MOLECULAR-BIOLOGY AND GENETICS OF HUMAN NEURO-BLASTOMA [J].
BRODEUR, GM ;
FONG, CT .
CANCER GENETICS AND CYTOGENETICS, 1989, 41 (02) :153-174
[4]   Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].
Caron, H ;
vanSluis, P ;
deKraker, J ;
Bokkerink, J ;
Egeler, M ;
Laureys, G ;
Slater, R ;
Westerveld, A ;
Voute, PA ;
Versteeg, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230
[5]   ALLELIC LOSS OF CHROMOSOME-1 AND ADDITIONAL CHROMOSOME-17 MATERIAL ARE BOTH UNFAVORABLE PROGNOSTIC MARKERS IN NEUROBLASTOMA [J].
CARON, H .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04) :215-221
[6]  
CHENG NC, 1995, ONCOGENE, V10, P291
[7]   TUMOR KARYOTYPE DISCRIMINATES BETWEEN GOOD AND BAD PROGNOSTIC OUTCOME IN NEURO-BLASTOMA [J].
CHRISTIANSEN, H ;
LAMPERT, F .
BRITISH JOURNAL OF CANCER, 1988, 57 (01) :121-126
[8]   CLINICAL IMPACT OF CHROMOSOME-I ABERRATIONS IN NEUROBLASTOMA - A METAPHASE AND INTERPHASE CYTOGENETIC STUDY [J].
CHRISTIANSEN, H ;
SCHESTAG, J ;
CHRISTIANSEN, NM ;
GRZESCHIK, KH ;
LAMPERT, F .
GENES CHROMOSOMES & CANCER, 1992, 5 (02) :141-149
[9]  
CHRISTIANSEN H, 1994, ADV NEUROBL RES, V4, P19
[10]   CYTOGENETIC EVOLUTION OF MYCN AND MDM2 AMPLIFICATION IN THE NEUROBLASTOMA LS TUMOR AND ITS CELL-LINE [J].
CORVI, R ;
SAVELYEVA, L ;
AMLER, L ;
HANDGRETINGER, R ;
SCHWAB, M .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) :520-523